Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 141st ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
AVBP	ARRIVENT BIOPHARMA INC	$19.59	-3.21%	-10.51%	-10.01%	-7.86%	-32.66%	-10.95%	N/A	N/A	N/A	$36.37	$15.47	46.14%	26.63%	0.82	277,000	32.54%
SNDX	SYNDAX PHARMACEUTICALS INC	$9.99	-3.48%	-2.25%	6.67%	-29.40%	-29.70%	-55.42%	-50.98%	-30.63%	N/A	$22.98	$8.58	56.53%	16.43%	1.06	2,132,000	-35.39%
AGIO	AGIOS PHARMACEUTICALS INC	$37.54	-0.50%	-7.45%	12.87%	26.44%	8.69%	-19.77%	76.33%	-20.89%	-65.53%	$62.58	$23.42	40.01%	60.32%	1.22	851,000	43.99%
ENGN	ENGENE HOLDINGS INC	$3.50	1.45%	-8.14%	-3.85%	-15.46%	-50.70%	-60.89%	-65.03%	N/A	N/A	$11.00	$2.65	68.18%	32.08%	0.12	38,500	11.27%
OCS	OCULIS HOLDING AG	$17.73	-2.04%	-1.99%	-8.66%	1.90%	-20.67%	62.07%	80.37%	N/A	N/A	$23.08	$10.79	23.18%	64.32%	0.25	36,000	-16.28%
HOWL	WEREWOLF THERAPEUTICS INC	$1.20	-7.69%	-13.67%	10.09%	33.04%	-11.11%	-51.02%	-73.97%	N/A	N/A	$4.18	$0.60	71.29%	101.68%	1.40	357,000	65.28%
IMUX	IMMUNIC INC	$0.96	-1.74%	-3.51%	37.82%	-2.83%	-5.69%	-31.29%	-72.44%	-94.50%	-99.82%	$2.11	$0.56	54.41%	71.48%	1.12	651,000	-50.27%
GPCR	STRUCTURE THERAPEUTICS INC	$17.83	0.17%	-1.82%	-14.03%	-33.96%	-41.19%	-50.60%	N/A	N/A	N/A	$45.37	$13.22	60.70%	34.87%	0.91	445,000	-40.75%
TPST	TEMPEST THERAPEUTICS INC	$7.54	3.86%	20.64%	10.88%	6.05%	-38.62%	-66.76%	-72.38%	-97.88%	-99.99%	$28.34	$5.35	73.39%	40.93%	2.54	71,400	-53.64%
PLRZ	POLYRIZON LTD	$1.26	-13.70%	-32.98%	70.50%	-98.37%	-99.62%	N/A	N/A	N/A	N/A	$1.20k	$0.55	99.90%	129.09%	-0.21	1,249,000	-63.65%
NGNE	NEUROGENE INC	$21.87	4.14%	-5.28%	46.29%	45.80%	40.82%	-44.10%	9.35%	-89.30%	-33.32%	$74.49	$6.88	70.64%	218.11%	1.41	195,000	6.56%
RVMD	REVOLUTION MEDICINES INC	$37.02	0.01%	-1.37%	0.61%	-8.33%	-14.06%	-18.02%	86.76%	63.71%	N/A	$62.40	$29.17	40.68%	26.89%	1.33	1,871,000	37.07%
INBX	INHIBRX BIOSCIENCES INC	$22.99	-5.23%	-0.91%	61.11%	86.46%	69.67%	60.99%	N/A	N/A	N/A	$25.29	$10.80	9.09%	112.87%	0.95	78,000	-29.73%
CYTK	CYTOKINETICS INC	$36.18	0.78%	-4.61%	9.50%	-15.55%	-27.60%	-39.86%	-11.99%	59.59%	494.09%	$59.81	$29.31	39.50%	23.44%	1.00	1,223,000	20.37%
SKYE	SKYE BIOSCIENCE INC	$3.61	0.00%	-17.20%	-13.64%	65.60%	-3.73%	-33.76%	N/A	4,412.50%	261.00%	$7.47	$1.14	51.67%	216.67%	142.66	168,000	-59.32%
MIST	MILESTONE PHARMACEUTICALS INC	$1.45	-0.68%	-9.38%	-25.26%	9.85%	-28.22%	-1.36%	-80.14%	-83.26%	N/A	$2.75	$0.63	47.27%	132.00%	0.87	1,224,000	-3.09%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$1.38	2.22%	-8.61%	18.97%	-2.82%	-16.87%	-66.50%	-95.21%	-96.06%	N/A	$5.44	$1.01	74.63%	36.63%	1.59	515,000	-27.36%
SLXN	SILEXION THERAPEUTICS CORP	$11.32	-8.78%	-14.37%	-6.83%	-23.37%	-63.19%	-99.29%	-99.15%	N/A	N/A	$1.83k	$8.63	99.38%	31.25%	0.44	30,600	-28.84%
BCTX	BRIACELL THERAPEUTICS CORP	$0.80	-0.25%	-3.25%	-72.69%	-82.00%	-85.58%	-92.72%	-99.16%	N/A	N/A	$29.40	$0.69	97.27%	16.38%	1.00	733,000	32.55%
OCUL	OCULAR THERAPEUTIX INC	$11.66	-0.77%	-2.51%	25.65%	40.48%	49.87%	40.82%	171.79%	43.77%	-50.68%	$12.35	$5.79	5.59%	101.56%	1.55	1,453,000	-13.51%
CTNM	CONTINEUM THERAPEUTICS INC	$6.01	15.58%	9.27%	51.39%	46.23%	-41.19%	-71.64%	N/A	N/A	N/A	$20.55	$3.35	70.75%	79.40%	0.81	300,000	63.93%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$9.26	-0.11%	5.35%	34.20%	23.96%	-6.46%	-84.47%	22.05%	-95.37%	-84.72%	$61.89	$4.64	85.04%	99.57%	1.60	95,000	-12.84%
ALMS	ALUMIS INC	$4.10	3.80%	6.77%	36.67%	-0.97%	-38.99%	-65.69%	N/A	N/A	N/A	$13.11	$2.76	68.73%	48.55%	0.66	882,000	-25.76%
SAVA	CASSAVA SCIENCES INC	$2.16	-2.26%	-20.00%	19.34%	38.46%	-9.24%	-87.71%	-87.97%	-32.08%	-82.47%	$42.20	$1.15	94.88%	87.83%	1.39	477,000	-42.53%
NKTR	NEKTAR THERAPEUTICS	$22.07	-3.67%	-11.72%	-14.59%	84.96%	72.98%	5.85%	-60.97%	-93.68%	-88.07%	$37.38	$6.48	40.96%	240.59%	1.65	545,000	-40.57%
ADVM	ADVERUM BIOTECHNOLOGIES INC	$2.39	-3.24%	-11.48%	11.16%	-26.69%	-45.80%	-67.79%	-82.68%	-98.65%	-98.33%	$8.56	$1.78	72.08%	34.27%	0.95	85,500	-9.04%
DNTH	DIANTHUS THERAPEUTICS INC	$20.80	-2.76%	-5.88%	11.65%	-4.81%	-4.46%	-28.55%	-17.20%	-81.77%	N/A	$32.27	$13.37	35.54%	55.63%	0.95	225,000	-33.43%
RNA	AVIDITY BIOSCIENCES INC	$36.88	2.59%	8.73%	29.86%	12.96%	13.02%	-18.59%	136.11%	31.67%	N/A	$56.00	$21.51	34.14%	71.46%	1.17	3,922,000	43.30%
VERA	VERA THERAPEUTICS INC	$21.09	1.79%	-6.81%	-10.48%	-9.76%	-43.73%	-39.08%	23.91%	N/A	N/A	$51.61	$18.53	59.14%	13.82%	1.13	904,000	-25.72%
CTXR	CITIUS PHARMACEUTICALS INC	$1.39	-5.44%	-15.76%	-12.58%	81.70%	-50.88%	-94.03%	-93.85%	-95.62%	N/A	$26.25	$0.65	94.70%	113.85%	0.88	466,000	39.94%
CDXS	CODEXIS INC	$2.79	-1.06%	-16.22%	14.34%	21.30%	-38.00%	-23.14%	-58.54%	-76.19%	-15.96%	$6.08	$1.90	54.11%	46.84%	1.96	596,000	-53.80%
IMVT	IMMUNOVANT INC	$16.62	-0.18%	-9.62%	3.88%	2.91%	-24.69%	-42.31%	322.90%	-26.82%	N/A	$34.47	$12.72	51.78%	30.66%	1.07	1,088,000	-14.33%
PYXS	PYXIS ONCOLOGY INC	$1.15	0.88%	-2.54%	4.55%	4.55%	-29.01%	-70.13%	-55.60%	N/A	N/A	$5.39	$0.83	78.66%	38.06%	1.10	148,000	-50.83%
ATNM	ACTINIUM PHARMACEUTICALS INC	$1.57	-2.48%	-16.04%	12.14%	3.29%	28.69%	-77.47%	-67.36%	-90.87%	-97.58%	$7.01	$1.03	77.60%	52.58%	1.18	205,000	6.22%
BHVN	BIOHAVEN LTD	$15.60	21.59%	13.54%	10.56%	-29.48%	-60.00%	-59.41%	N/A	N/A	N/A	$55.70	$12.80	71.99%	21.88%	1.69	7,154,000	296.56%
ZURA	ZURA BIO LTD	$1.44	-2.04%	-14.79%	37.14%	-6.49%	-18.18%	-61.39%	-85.56%	N/A	N/A	$5.07	$0.97	71.60%	48.45%	0.20	289,000	-28.99%
CDT	CONDUIT PHARMACEUTICALS INC	$1.77	-5.85%	-18.43%	-35.87%	-78.85%	-95.37%	-99.46%	-99.99%	N/A	N/A	$622.50	$1.75	99.72%	1.14%	-0.04	96,000	43.28%
WVE	WAVE LIFE SCIENCES LTD	$8.16	-1.92%	-4.67%	25.54%	5.70%	-32.34%	24.39%	241.42%	-8.31%	N/A	$16.74	$5.04	51.24%	61.90%	1.42	1,930,000	27.14%
RCUS	ARCUS BIOSCIENCES INC	$9.43	-1.87%	-3.28%	15.85%	7.77%	-29.52%	-40.24%	-62.08%	-55.85%	N/A	$18.98	$6.50	50.32%	45.08%	1.52	545,000	-31.88%
PLRX	PLIANT THERAPEUTICS INC	$1.52	4.11%	-3.80%	31.03%	-4.40%	-85.74%	-89.10%	-90.79%	-93.68%	N/A	$16.10	$1.10	90.56%	38.18%	1.02	577,000	42.47%
KAPA	KAIROS PHARMA LTD	$0.94	9.18%	-4.08%	32.58%	15.91%	-36.49%	N/A	N/A	N/A	N/A	$4.00	$0.40	76.50%	135.00%	0.25	964,000	116.63%
ACHV	ACHIEVE LIFE SCIENCES INC	$2.67	4.71%	-2.20%	18.14%	2.69%	-17.59%	-45.84%	-46.39%	-77.75%	-99.96%	$5.31	$1.84	49.72%	45.11%	0.93	543,000	-20.50%
DYN	DYNE THERAPEUTICS INC	$9.91	7.72%	5.65%	4.10%	-15.95%	-29.92%	-76.88%	-6.69%	N/A	N/A	$47.45	$6.36	79.11%	55.82%	1.47	3,002,000	25.03%
KPTI	KARYOPHARM THERAPEUTICS INC	$4.05	-1.94%	-16.67%	-6.03%	-40.00%	-59.34%	-74.53%	-93.38%	-98.37%	-98.66%	$16.95	$3.51	76.11%	15.38%	1.25	43,700	-49.54%
TNGX	TANGO THERAPEUTICS INC	$6.30	-2.40%	-8.43%	23.05%	346.81%	102.57%	-35.05%	65.35%	N/A	N/A	$12.02	$1.03	47.57%	511.65%	1.18	3,189,000	97.22%
BMEA	BIOMEA FUSION INC	$1.66	0.61%	-10.27%	-7.78%	-20.95%	-60.94%	-68.80%	-84.19%	N/A	N/A	$13.07	$1.29	87.30%	28.68%	1.03	539,000	-39.44%
ATXS	ASTRIA THERAPEUTICS INC	$6.73	1.20%	0.75%	25.56%	30.43%	-10.15%	-41.12%	73.90%	-80.99%	-99.20%	$12.92	$3.56	47.91%	89.31%	0.99	322,000	34.17%
CBUS	CIBUS INC	$1.51	-2.58%	-13.71%	9.42%	-29.77%	-40.78%	-85.00%	-86.83%	-99.34%	N/A	$10.01	$1.38	84.91%	9.42%	1.36	214,000	101.89%
DSGN	DESIGN THERAPEUTICS INC	$4.03	1.26%	-5.62%	19.58%	-17.08%	-18.91%	-19.40%	-78.31%	N/A	N/A	$7.77	$2.60	48.13%	55.00%	1.43	64,600	-61.08%
FBLG	FIBROBIOLOGICS INC	$0.64	4.61%	-4.08%	2.09%	-43.30%	-61.98%	-87.69%	N/A	N/A	N/A	$5.40	$0.58	88.24%	9.48%	0.33	580,000	-37.57%
MRSN	MERSANA THERAPEUTICS INC	$6.75	-2.88%	-33.43%	-8.78%	-37.63%	-57.60%	-86.43%	-94.43%	-98.66%	N/A	$70.75	$6.47	90.46%	4.28%	1.65	142,000	-25.26%
DNLI	DENALI THERAPEUTICS INC	$13.67	0.44%	-5.53%	-2.29%	-17.90%	-42.03%	-43.54%	-58.29%	-42.99%	N/A	$33.33	$10.57	58.99%	29.33%	1.56	2,061,000	32.28%
DTIL	PRECISION BIOSCIENCES INC	$4.80	-1.84%	-2.83%	14.29%	-14.89%	-7.87%	-49.74%	-88.81%	-97.72%	N/A	$11.09	$3.61	56.72%	32.96%	1.31	120,000	96.72%
KALV	KALVISTA PHARMACEUTICALS INC	$13.84	0.65%	-11.05%	22.42%	0.51%	57.81%	-3.01%	13.35%	37.17%	-85.92%	$16.32	$7.30	15.20%	89.59%	0.81	924,000	-5.91%
PRAX	PRAXIS PRECISION MEDICINES INC	$56.59	1.13%	-0.88%	34.58%	50.35%	-25.73%	-0.51%	16.80%	N/A	N/A	$91.83	$26.70	38.38%	111.95%	1.14	547,000	14.20%
REPL	REPLIMUNE GROUP INC	$7.55	101.33%	126.39%	-18.73%	-22.80%	-44.57%	-25.25%	-59.80%	-62.16%	N/A	$17.00	$2.68	55.59%	181.72%	1.04	202,083,000	766.05%
PEPG	PEPGEN INC	$1.38	0.00%	-5.48%	24.32%	-12.10%	-4.17%	-91.87%	-87.03%	N/A	N/A	$11.28	$0.88	87.76%	56.82%	1.30	113,000	43.04%
CRDF	CARDIFF ONCOLOGY INC	$2.49	-24.77%	-41.96%	-20.95%	-9.12%	-37.28%	9.21%	28.35%	-45.87%	-99.56%	$5.64	$2.01	55.84%	23.88%	1.43	14,434,000	75.81%
NMRA	NEUMORA THERAPEUTICS INC	$2.08	-5.02%	12.43%	183.77%	166.67%	8.33%	-83.76%	N/A	N/A	N/A	$17.19	$0.61	87.90%	240.43%	1.33	1,007,000	-45.12%
CVKD	CADRENAL THERAPEUTICS INC	$10.54	-3.04%	-10.07%	-12.53%	-35.81%	-44.61%	61.51%	N/A	N/A	N/A	$22.90	$5.70	53.98%	84.91%	0.80	14,400	0.70%
LXEO	LEXEO THERAPEUTICS INC	$4.65	13.41%	19.23%	15.67%	18.32%	-11.43%	-63.44%	N/A	N/A	N/A	$13.63	$1.45	65.88%	220.69%	1.93	1,356,000	391.30%
WINT	WINDTREE THERAPEUTICS INC	$0.77	-5.52%	-20.86%	48.08%	-34.19%	-88.51%	-99.73%	-100.00%	-100.00%	-100.00%	$737.44	$0.36	99.90%	113.89%	0.89	1,933,000	-69.90%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$2.41	-2.82%	-8.02%	0.00%	19.31%	-52.28%	-74.58%	-90.57%	N/A	N/A	$9.95	$1.67	75.78%	44.74%	1.04	999,000	-14.83%
BCYC	BICYCLE THERAPEUTICS PLC	$8.51	-0.12%	-2.30%	22.45%	-0.58%	-33.36%	-64.76%	-62.48%	-47.16%	N/A	$28.67	$6.10	70.32%	39.51%	1.04	178,000	-45.73%
VKTX	VIKING THERAPEUTICS INC	$33.71	2.43%	0.93%	27.21%	16.76%	0.06%	-40.36%	1,074.56%	347.08%	425.08%	$81.73	$18.92	58.75%	78.17%	1.21	3,333,000	-12.86%
DWTX	DOGWOOD THERAPEUTICS INC	$4.87	1.46%	1.04%	2.10%	-11.13%	-61.83%	-7.45%	-97.24%	N/A	N/A	$29.28	$1.62	83.37%	200.62%	0.82	28,500	-14.16%
CYBN	CYBIN INC	$7.30	-3.57%	-5.93%	-12.99%	8.63%	-26.85%	-29.63%	-69.02%	N/A	N/A	$13.88	$4.81	47.41%	51.77%	0.85	290,000	-19.89%
LRMR	LARIMAR THERAPEUTICS INC	$3.57	1.13%	-5.05%	23.53%	34.72%	-10.08%	-58.29%	115.06%	-68.96%	-99.17%	$9.50	$1.61	62.42%	121.74%	1.04	4,396,000	211.77%
RXRX	RECURSION PHARMACEUTICALS INC	$5.81	-2.35%	-9.64%	14.82%	3.94%	-24.45%	-26.92%	-30.00%	N/A	N/A	$12.36	$3.79	52.99%	53.30%	2.28	20,497,000	-13.67%
CHRS	COHERUS BIOSCIENCES INC	$0.97	-3.96%	-0.92%	32.69%	-5.83%	-28.15%	-37.01%	-89.41%	-94.66%	-97.12%	$2.43	$0.66	60.08%	46.97%	1.49	1,455,000	-9.01%
CERO	CERO THERAPEUTICS HOLDINGS INC	$7.00	-3.05%	-14.95%	-27.31%	-60.67%	-82.41%	-97.76%	-99.97%	N/A	N/A	$895.40	$6.71	99.22%	4.32%	0.20	43,300	-34.39%
CABA	CABALETTA BIO INC	$1.56	-0.64%	-2.50%	2.63%	18.18%	-33.33%	-77.55%	35.65%	-86.32%	N/A	$7.22	$0.99	78.39%	58.22%	1.32	951,000	26.80%
JSPR	JASPER THERAPEUTICS INC	$2.96	0.34%	-9.48%	-46.67%	-46.08%	-55.82%	-83.97%	-85.20%	-97.11%	N/A	$26.05	$2.27	88.64%	30.68%	0.67	382,000	-9.05%
IMRN	IMMURON LTD	$1.67	0.60%	-4.57%	-4.02%	-11.17%	-22.69%	-33.20%	-26.75%	-84.32%	N/A	$2.87	$1.50	41.81%	11.33%	0.78	77,000	14.93%
SONN	SONNET BIOTHERAPEUTICS HOLDINGS INC	$3.22	-1.23%	-29.54%	159.68%	125.17%	86.13%	-49.98%	-99.52%	-99.96%	-100.00%	$19.30	$1.08	83.32%	198.15%	0.82	447,000	-59.98%
XRTX	XORTX THERAPEUTICS INC	$0.74	0.82%	-18.22%	-18.67%	-27.84%	-22.53%	-57.94%	-94.20%	N/A	N/A	$2.98	$0.72	75.30%	2.22%	0.17	36,000	-76.47%
ERNA	ERNEXA THERAPEUTICS INC	$1.85	3.35%	-16.29%	0.54%	-40.42%	-66.34%	-93.17%	-98.74%	-99.85%	-99.97%	$29.25	$1.71	93.68%	8.19%	1.14	73,400	195.97%
LPTX	LEAP THERAPEUTICS INC	$0.32	-3.59%	-9.80%	8.42%	-22.97%	-37.96%	-85.23%	-96.90%	-98.47%	N/A	$4.79	$0.22	93.28%	45.05%	1.27	226,000	-34.11%
CAPS	CAPSTONE HOLDING CORP	$1.67	-6.18%	-0.60%	-7.22%	-5.11%	N/A	N/A	N/A	N/A	N/A	$4.18	$1.30	60.05%	28.46%	1.55	372,000	279.59%
DYAI	DYADIC INTERNATIONAL INC	$1.13	-3.83%	2.73%	14.14%	-7.38%	-24.16%	-18.12%	-60.21%	-86.98%	N/A	$2.20	$0.91	48.64%	23.90%	0.77	113,000	17.71%
ADXN	ADDEX THERAPEUTICS LTD	$8.30	1.97%	-0.84%	-11.80%	6.52%	13.54%	3.79%	-64.22%	-95.41%	N/A	$13.27	$6.51	37.45%	27.50%	0.48	300	-87.50%
ANEB	ANEBULO PHARMACEUTICALS INC	$2.88	-5.88%	-13.51%	100.00%	138.02%	81.13%	30.91%	-2.70%	N/A	N/A	$3.42	$0.80	15.79%	260.00%	0.53	338,000	52.94%
AKTX	AKARI THERAPEUTICS PLC	$1.01	-6.48%	-11.01%	-13.68%	-29.86%	-25.19%	-72.40%	-95.79%	-97.55%	-99.13%	$4.22	$0.85	76.06%	18.82%	0.39	12,400	-56.94%
KLRS	KALARIS THERAPEUTICS INC	$2.69	0.00%	-2.89%	0.75%	-57.10%	-71.41%	-84.50%	-97.45%	-99.54%	N/A	$24.15	$2.28	88.86%	17.98%	1.47	15,000	-79.45%
ABP	ABPRO HOLDINGS INC	$0.30	-5.99%	2.05%	39.91%	24.69%	-71.07%	-97.31%	-97.02%	N/A	N/A	$13.00	$0.15	97.71%	96.05%	0.41	8,121,000	-57.88%
LPCN	LIPOCINE INC	$3.33	1.83%	1.83%	5.38%	0.60%	-25.50%	-33.53%	-75.11%	-87.03%	-98.39%	$6.17	$2.68	46.01%	24.07%	0.80	6,900	-56.88%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$5.29	-5.20%	4.55%	-8.16%	29.02%	76.33%	92.36%	N/A	N/A	N/A	$6.20	$2.20	14.68%	140.45%	0.54	26,200	367.86%
ENVB	ENVERIC BIOSCIENCES INC	$1.23	0.00%	-10.22%	1.65%	-6.82%	-68.46%	-85.90%	-98.67%	-99.98%	N/A	$8.95	$1.01	86.26%	21.78%	1.52	48,500	-50.51%
ENTX	ENTERA BIO LTD	$2.02	0.00%	4.66%	6.32%	-6.91%	-13.30%	27.85%	12.85%	16.09%	N/A	$2.79	$1.41	27.60%	43.26%	0.56	110,000	-28.10%
ACXP	ACURX PHARMACEUTICALS INC	$0.33	-12.47%	-26.17%	-35.42%	-23.26%	-56.52%	-85.07%	-91.13%	N/A	N/A	$2.39	$0.30	86.19%	10.00%	0.54	3,069,000	491.33%
ENLV	ENLIVEX THERAPEUTICS LTD	$1.54	8.45%	31.62%	37.50%	50.98%	38.74%	16.23%	-63.76%	-72.40%	-99.42%	$1.76	$0.81	12.50%	90.12%	0.85	1,012,000	55.69%
LEXX	LEXARIA BIOSCIENCE CORP	$0.92	2.92%	-11.17%	5.17%	-21.12%	-49.73%	-75.07%	-66.85%	-92.56%	-78.97%	$4.38	$0.79	79.11%	15.24%	0.71	314,000	88.02%
ANL	ADLAI NORTYE LTD	$1.41	-1.26%	-4.08%	-4.08%	-23.37%	-31.55%	-59.04%	N/A	N/A	N/A	$3.89	$1.10	63.75%	28.18%	0.64	1,300	-64.86%
ATNF	180 LIFE SCIENCES CORP	$3.52	9.16%	53.49%	278.77%	294.94%	144.10%	50.86%	-99.19%	-99.92%	N/A	$17.75	$0.66	80.20%	434.19%	1.13	4,263,000	-44.76%
APLM	APOLLOMICS INC	$5.75	-6.35%	-3.69%	-12.32%	-12.75%	-35.68%	-71.67%	-99.43%	N/A	N/A	$35.98	$4.47	84.02%	28.64%	0.12	14,700	-73.75%
GNFT	GENFIT SA	$3.97	-3.64%	-2.46%	6.58%	-3.05%	0.00%	-6.37%	-10.59%	-17.12%	N/A	$6.42	$2.55	38.19%	55.69%	0.23	900	-5.26%
THAR	THARIMMUNE INC	$1.32	-1.49%	-20.48%	-31.96%	-23.70%	-33.33%	-62.18%	-99.68%	N/A	N/A	$6.39	$0.95	79.34%	38.66%	0.76	38,300	-37.21%
NCNA	NUCANA PLC	$0.05	-6.00%	-11.32%	-17.54%	-92.03%	-95.44%	-98.63%	-99.90%	-99.96%	N/A	$10.79	$0.03	99.56%	42.42%	0.95	129,205,000	-42.62%
DRTS	ALPHA TAU MEDICAL LTD	$2.90	0.00%	-3.65%	-7.05%	13.28%	-23.68%	31.82%	-73.10%	N/A	N/A	$4.39	$1.93	33.90%	50.26%	0.37	39,700	-10.99%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$0.84	-4.11%	-11.58%	-5.62%	42.13%	42.37%	-89.65%	-98.08%	-97.95%	N/A	$8.50	$0.48	90.12%	76.84%	0.99	47,600	32.22%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 49, which is 26 points higher than the biotech industry average of 23.

PBYI passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock lose -12.71% over the past year, overperforming other biotech stocks by 55 percentage points.

Puma Biotechnology has an average 1 year price target of $7.00, an upside of 121.52% from Puma Biotechnology's current stock price of $3.16.

Puma Biotechnology stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ptc Therapeutics (NASDAQ:PTCT)

Ptc Therapeutics (NASDAQ:PTCT) is the #2 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

PTCT passed 11 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 54.22% over the past year, overperforming other biotech stocks by 122 percentage points.

Ptc Therapeutics has an average 1 year price target of $69.62, an upside of 36.66% from Ptc Therapeutics's current stock price of $50.94.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 53.85% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 0% have issued a Sell rating, and 7.69% have issued a Strong Sell.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #3 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

RIGL passed 11 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 97.46% over the past year, overperforming other biotech stocks by 165 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $39.75, an upside of 89.2% from Rigel Pharmaceuticals's current stock price of $21.01.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Rigel Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.26%, which is 5 percentage points higher than the biotech industry average of 1.87%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 3.22%, which is 1 percentage points higher than the biotech industry average of 1.87%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.75%, which is the same as the biotech industry average of 1.87%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.35% in the last day, and down -2.52% over the last week. Vyne Therapeutics was the among the top losers in the biotechnology industry, dropping -72.36% yesterday.

VYNE Therapeutics shares are trading lower after the company announced its Phase 2b trial Repibresib Gel in nonsegmental vitiligo did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -12.71% in the past year. It has overperformed other stocks in the biotech industry by 55 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 4.75% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

3. United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -16.47% in the past year. It has overperformed other stocks in the biotech industry by 51 percentage points.

Are biotech stocks a good buy now?

53.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 101.38% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.23% of biotech stocks are rated B (Buy), 37.42% are rated C (Hold), 35.94% are rated D (Sell), and 20.3% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -199.97x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Ptc Therapeutics (NASDAQ:PTCT)

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Ptc Therapeutics (NASDAQ:PTCT)

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.